2016 WMIF | Combination Cancer Therapies: Drug Resistance and Therapeutic Index скачать в хорошем качестве

2016 WMIF | Combination Cancer Therapies: Drug Resistance and Therapeutic Index

Moderator: Jens Eckstein, PhD, President, SR One Kenneth Anderson, MD, Director, Jerome Lipper Multiple Myeloma Center, Kraft Family Professor of Medicine, Harvard Medical School Jeffrey Engelman, MD, PhD, Director, Thoracic Oncology and Director, Molecular Therapeutics, Medical Oncology, MGH, Laurel Schwartz Associate Professor of Medicine, Harvard Medical School Jamie Freedman, MD, PhD, Senior Vice President, Global Clinical Development, Medimmune David Schenkein, MD, CEO, Agios Pharmaceuticals William Sellers, MD, Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research Study Designs to Meet the Challenges of Personalized Cancer Medicine Game changing modern cancer therapies—immunotherapies and targeted therapies, among others—do not by themselves meet the needs of many patients who require alternative strategies to achieve optimal therapeutic benefit. Panel experts will describe combining these therapies with other drugs, challenges and the path forward.